Cue Biopharma, Inc. (CUE) (CIK 0001645460) (CUE)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Aug. 18, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 18, 2026 | CORRESP | Neutral/Informational | Moderate | Cue Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking to have the stateme… | Read Filing EDGAR |
| Aug. 17, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Cue Biopharma, Inc. that they will not review the company's registration statement filed on August 12, 2026. The letter emphasizes the company's respon… | Read Filing EDGAR |
| Jun. 29, 2026 | CORRESP | Neutral/Informational | Moderate | Cue Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. The company aims for the registratio… | Read Filing EDGAR |
| Jun. 25, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Cue Biopharma, Inc. that they will not review the company's registration statement filed on June 18, 2026. The letter emphasizes the company's responsi… | Read Filing EDGAR |
| Jun. 15, 2026 | CORRESP | Neutral/Informational | Moderate | Cue Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking to have the registr… | Read Filing EDGAR |
| Jun. 10, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Cue Biopharma, Inc. that it will not review the company's registration statement filed on June 3, 2026. The letter emphasizes that the responsibility f… | Read Filing EDGAR |
| Mar. 27, 2026 | CORRESP | Neutral/Informational | Moderate | Cue Biopharma, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3, originally filed on March 16, 2026. The company a… | Read Filing EDGAR |
| Mar. 23, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Cue Biopharma, Inc. that they will not review the company's registration statement filed on March 16, 2026. The SEC has reminded the company that it is… | Read Filing EDGAR |